Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Palladium-catalyzed intramolecular dearomatization of indoles via Heck/Stille cross-coupling with organostannanes

Zhenjie Qi *a, Jiajing Hongb, Baojing Jia, Chen Chena, Yixuan Xiaoa, Boxuan Songa, Yanguo Lva, Zhenyu An*b and Peipei Ma*b
aSchool of Resource & Environment and Safety Engineering, Jining University, Qufu 273155, Shandong, China. E-mail: 202310001@jnxy.edu.cn
bSchool of Pharmacy, Ningxia Medical University, Yinchuan 750000, Ningxia, China

Received 15th March 2026 , Accepted 17th April 2026

First published on 30th April 2026


Abstract

A palladium-catalyzed tandem intramolecular Heck cyclization/intermolecular Stille coupling for the dearomatization of N-(2-bromobenzoyl)indoles is described. This organotin-based protocol provides fused indoline derivatives bearing contiguous quaternary carbon stereocenters at the C2 and C3 positions in moderate to excellent yields and is compatible with structurally diverse organotin reagents, including aryl-, naphthyl-, vinyl ether-, alkenyl-, and alkyl-substituted stannanes. Moreover, this protocol is characterized by mild conditions and gram-scale scalability.


In recent years, transition-metal-catalyzed dearomatization reactions have emerged as a powerful tool for the efficient construction of a diverse array of three-dimensional complex molecules bearing multiple chiral centers. This strategy has markedly enhanced synthetic efficiency and thus provided a pivotal approach for the synthesis of pharmaceuticals, natural products, and the development of functional materials.1 Among such compounds, polycyclic fused indolines containing quaternary carbon stereocenters possess rigid three-dimensional architectures and unique electronic properties originating from their fused-ring skeletons. These scaffolds not only serve as the core structural motifs of numerous natural alkaloids and pharmaceutical molecules but also act as important precursors for the fabrication of chiral ligands and functional materials.2 Representative examples include (−)-isatisine A,3 (±)-mersicarpine,4 gliocladin C,5 brevianamide E6 and strychnine (Fig. 1).7 Recently, the mainstream strategy for synthesizing tetracyclic fused indolines relies on the intramolecular dearomative Heck reaction of N-(2-halobenzoyl)indoles. This transformation generates a key benzyl-palladium intermediate, which can either be trapped by a diverse array of nucleophiles including hydrides, cyanides, organoboron reagents, alkynes, and azoles or undergo transformation via β-hydride elimination.8
image file: d6ra02185a-f1.tif
Fig. 1 Some representative natural products and bioactive molecules.

Nevertheless, synthetic methodologies for the preparation of C3-aryl-substituted tetracyclic fused indolines remain scarce, with existing approaches primarily focused on the Suzuki coupling of N-substituted indoles with arylboronic acids or arylboroxines.9 In 2016, Lautens and co-workers reported a palladium-catalyzed dearomative 1,2-diarylation of N-(2-bromobenzoyl)indoles using triphenylboroxine as the coupling partner, which successfully afforded C3-aryl-substituted polycyclic fused indolines (Scheme 1a).9c In 2021, Zhao's group developed a palladium-catalyzed asymmetric dearomative cyclization of indoles with phenylboronic acids, enabling the stereoselective construction of 3-arylindoline derivatives.9a In the same year, Liang's group adopted a similar strategy for the synthesis of tetracyclic indoline frameworks (Scheme 1b).9b Inspired by these pioneering studies, herein we report a one-pot protocol for the construction of C3-aryl-substituted polycyclic fused indolines. This methodology is based on the palladium-catalyzed dearomatization of N-substituted indoles with stable and readily accessible organotin reagents as coupling partners, proceeding via a sequential Heck coupling/Stille coupling cascade process.


image file: d6ra02185a-s1.tif
Scheme 1 Approaches to 3-aryl-substituted indoline derivatives via palladium-catalyzed dearomatization.

Initially, N-(2-bromobenzoyl)-2-methylindole (1a) and tributyl(phenyl)stannane (2a) were selected as model substrates for the sequential Heck/Stille cross-coupling reaction, and the transformation was investigated under a palladium/ligand catalytic system (Table 1). The dearomatization reaction was first conducted with Pd(OAc)2/PCy3·HBF4 as the catalytic system, K2CO3 as the base, in 1,2-dichloroethane (DCE) at 100 °C under nitrogen protection for 12 h, affording the target product 3aa in 55% yield (Table 1, entry 1). The structure of 3aa was unambiguously confirmed by single-crystal X-ray diffraction, providing a solid foundation for subsequent optimization and scope studies. To improve the reaction yield, a systematic series of optimization experiments was subsequently performed. First, various organic solvents were screened, including THF, DCM, 1,4-dioxane and toluene, yet none delivered a superior yield to DCE (Table 1, entries 2–5). Next, a range of phosphine ligands was evaluated to enhance catalytic activity. When PtBu3·HBF4, PPh3, DPPB and XPhos were tested individually, the use of PPh3 as the ligand led to a slight increase in yield, affording 3aa in 66% yield (Table 1, entries 6–9). We then focused on the screening of inorganic bases, given that the base plays a pivotal role in modulating reaction kinetics and product formation. The results demonstrated that K3PO4 outperformed K2CO3 significantly, furnishing 3aa in an excellent yield of 87% (Table 1, entry 12). In contrast, other bases including Na2CO3, NaHCO3, NaOAc, and Na2HPO4 exhibited poorer efficacy in promoting this transformation (Table 1, entries 10, 11 and 13 and 14). Finally, a variety of palladium precatalysts, including PdCl2(CH3CN)2 and Pd(dba)2, were screened to identify the optimal catalytic precursor. Among these, Pd(OAc)2 remained the optimal choice, as the other palladium sources resulted in a notable decrease in yield (Table 1, entries 15 and 16). On the basis of the above optimization studies, the optimal reaction conditions were established as follows: 5 mol% Pd(OAc)2 as the precatalyst, 10 mol% PPh3 as the ligand, 2.0 equiv. K3PO4 as the base, and DCE as the solvent, with stirring at 100 °C under an N2 atmosphere for 12 h (Table 1, entry 12).

Table 1 Optimization of reaction conditionsa

image file: d6ra02185a-u1.tif

Entry [Pd] Ligand Base Solvent Yieldb %
a Reaction conditions: 1a (0.2 mmol), 2a (0.3 mmol), [Pd] (5 mol%), ligand (10 mol%), base (2.0 equiv.) and solvent (4.0 mL), at 100 °C under N2 atmosphere for 12 h.b Isolated yield.
1 Pd(OAc)2 PCy3·HBF4 K2CO3 DCE 55
2 Pd(OAc)2 PCy3·HBF4 K2CO3 THF 25
3 Pd(OAc)2 PCy3·HBF4 K2CO3 DCM 43
4 Pd(OAc)2 PCy3·HBF4 K2CO3 Dioxane 36
5 Pd(OAc)2 PCy3·HBF4 K2CO3 Toluene 30
6 Pd(OAc)2 PtBu3·HBF4 K2CO3 DCE 45
7 Pd(OAc)2 PPh3 K2CO3 DCE 66
8 Pd(OAc)2 DPPB K2CO3 DCE 40
9 Pd(OAc)2 XPhos K2CO3 DCE 28
10 Pd(OAc)2 PPh3 Na2CO3 DCE 60
11 Pd(OAc)2 PPh3 NaHCO3 DCE 59
12 Pd(OAc)2 PPh3 K3PO4 DCE 87
13 Pd(OAc)2 PPh3 NaOAc DCE 45
14 Pd(OAc)2 PPh3 Na2HPO4 DCE 68
15 PdCl2(CH3CN)2 PPh3 K3PO4 DCE 60
16 Pd(dba)2 PPh3 K3PO4 DCE 59


With the optimized conditions established, we further explored the substrate scope of this dearomative cascade transformation. We first evaluated N-(2-bromobenzoyl)-2-methylindole (1a) and its ring-substituted derivatives, results summarized in Table 2. Indole substrates with various C2 substituents (alkyl/aryl groups) were also compatible, delivering 3aa–3pa in moderate to good yields. It is noteworthy that substrates bearing an aryl group at the C2 position of the indole ring generally afforded lower yields (50–79%) compared to the methyl-substituted analogue 1a (87%). This is due to the larger size of the aryl group and altered electronic effects, which impede the key Heck insertion step by increasing steric congestion around the palladium center. Unsubstituted C2 afforded product 3pa only in 36% yield, much lower than substituted analogues. This is presumably due to the unsubstituted indole's propensity for Heck homocoupling side reactions, reducing the desired product yield. C2 alkyl-substituted indoles (e.g., cyclopropyl) afforded 3ba in 60% yield. Replacement of C2–H with a phenyl group (either EWG- or EDG-substituted) enabled smooth reaction (3ca–3ma). Steric hindrance was negligible, with moderate yields maintained for ortho-, meta-, and para-substituted phenyl groups. C2 substituents such as 2-naphthyl and 2-thienyl (heteroaromatic) also gave good yields (3na–3oa), confirming the catalytic system's broad substrate tolerance. The reaction proceeded smoothly when C5/C6 positions of the indole ring bore diverse functional groups, affording products 3qa–3ua in 62–97% yields. A distinct electronic trend was observed: the electron-donating group (EDG)-substituted substrate 3ra gave an excellent 97% yield, significantly higher than those with electron-withdrawing groups (EWGs) (3sa–3ua).

Table 2 Substrate scope of substituted isoindolo[2,1-a]indol-6-onea
a Reaction conditions: 1 (0.2 mmol), 2 (0.3 mmol), [Pd] (5 mol%), ligand (10 mol%), base (2.0 equiv.) and solvent (4.0 mL), at 100 °C under N2 atmosphere for 12 h.
image file: d6ra02185a-u2.tif


We further extended the study to the scope of organotin reagents with indoles (Table 2). Phenyl-substituted organotin substrates bearing EDGs (methoxy), EWGs (fluoro, formyl) or a phenyl group all reacted smoothly, affording 3ab–3ae in 54–78% yields. Gratifyingly, replacing the phenyl group with 1-naphthyl or 2-naphthyl also enabled efficient transformation, giving the products 3af–3ag in 62% and 75% yields, respectively. Notably, vinyl ether-, alkenyl-, and alkyl-substituted organotin reagents were likewise competent coupling partners, furnishing 3ah–3ak in 79–85% yields. These results further expand the catalytic system's applicability to structurally diverse organotin reagents. The relative configuration of the C2 and C3 quaternary stereocenters was established as cis by X-ray crystallography of 3aa, and all other products were assigned as single diastereomers with the same relative configuration on the basis of the rigid fused-ring system.

To demonstrate the scalability of this palladium-catalyzed dearomatization reaction, a gram-scale experiment was conducted (Scheme 2).10 Product 3aa was scaled up in 10.0 mL DCE at 100 °C for 15 h, using the standard catalytic system (5 mol% Pd(OAc)2, 10 mol% PPh3, 2.0 equiv. K3PO4). Gratifyingly, the desired product 3aa was isolated in a synthetically useful 74% yield, verifying the transformation's practical applicability.


image file: d6ra02185a-s2.tif
Scheme 2 Gram-scale reaction.

Based on our experimental results and published literature, a plausible catalytic cycle for the palladium-catalyzed dearomative cyclization reaction is proposed in Scheme 3.11 Pd(0) species are in situ generated from Pd(OAc)2 and PPh3 ligands, which undergo oxidative addition with the C–Br bond of aryl bromide 1a to form arylpalladium complex A. Subsequent coordination of the indole C2[double bond, length as m-dash]C3 bond to the palladium center, followed by intramolecular migratory insertion, furnishes dearomatized alkylpalladium(II) intermediate C via transition state B. Intermediate C then undergoes transmetalation with tributylphenylstannane (2a) to form an alkyl(aryl)palladium(II) intermediate D. Finally, reductive elimination of D yields target product 3aa and releases Pd(0) to perpetuate the catalytic cycle.


image file: d6ra02185a-s3.tif
Scheme 3 Proposed reaction mechanism.

In summary, we have developed a palladium-catalyzed tandem intramolecular Heck cyclization/intermolecular Stille coupling for the dearomatization of N-(2-bromobenzoyl)indoles. This method provides fused indoline frameworks bearing contiguous quaternary carbon centers at the C2 and C3 positions, with a substrate scope encompassing a range of indoles and structurally diverse organotin reagents. Gram-scale synthesis of 3aa further demonstrates the synthetic utility of this complementary Heck/Stille cascade.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: experimental procedures spectroscopic data. See DOI: https://doi.org/10.1039/d6ra02185a.

Acknowledgements

We are grateful for the support from Youth Innovation Technology Project of Higher School in Shandong Province (2025KJH080), Natural Science Foundation of Shandong Province (Grant No. ZR2024QB354), Ningxia Key Research and Development Program (2022BSB03052), Ningxia Natural Science Foundation Program (2025AAC030639).

References

  1. (a) S. Dutta, D. Lee, K. Ozols, C. G. Daniliuc, R. Shintani and F. Glorius, J. Am. Chem. Soc., 2024, 146, 2789–2797 CrossRef CAS PubMed; (b) Y.-M. He, Y.-Z. Cheng, Y. Duan, Y.-D. Zhang, Q.-H. Fan, S.-L. You, S. Luo, S.-F. Zhu, X.-F. Fu and Q.-L. Zhou, CCS Chem., 2023, 5, 2685–2716 CrossRef CAS; (c) M. Laugeois, J. Ling, C. Férard, V. Michelet, V. Ratovelomanana-Vidal and M. R. Vitale, Org. Lett., 2017, 19, 2266–2269 CrossRef CAS PubMed; (d) R. R. Liu, Y. G. Wang, Y. L. Li, B. B. Huang, R. X. Liang and Y. X. Jia, Angew. Chem., Int. Ed., 2017, 56, 7475–7478 CrossRef CAS PubMed.
  2. (a) M. Lv, X. Yu, J. Liu and X. Li, ACS Catal., 2025, 15, 255–264 CrossRef CAS; (b) A. Pareek, M. Y. Mehboob, M. Cieplak, M. Majdecki, H. Szabat, K. Noworyta, P. Poczyński, M. Morawiak, P. S. Sharma and C. Foroutan-Nejad, J. Am. Chem. Soc., 2025, 147, 5996–6005 CrossRef CAS PubMed; (c) S. A. Samsoniya, M. V. Trapaidze, N. N. Nikoleishvili, K. G. Japaridze, J. P. Maisuradze and U. Kazmaier, Chem. Heterocycl. Compd., 2010, 46, 1016–1019 CrossRef CAS; (d) A. Schmid, G. Romey, J. Barhanin and M. Lazdunski, Mol. Pharmacol., 1989, 35, 766–769 CrossRef CAS PubMed; (e) D. Zhao and Y. Li, Synfacts, 2025, 21, 464 CrossRef; (f) R. A. Jagtap, P. P. Samal, C. P. Vinod, S. Krishnamurty and B. Punji, ACS Catal., 2020, 10, 3712–3721 Search PubMed.
  3. (a) J. F. Liu, Z. Y. Jiang, R. R. Wang, Y. T. Zheng, J.-J. Chen, X.-M. Zhang and Y. B. Ma, Org. Lett., 2007, 9, 4127–4129 CrossRef CAS PubMed; (b) P. Patel, B. Narendraprasad Reddy and C. V. Ramana, Tetrahedron, 2014, 70, 510–516 CrossRef CAS; (c) X. Zhang, T. Mu, F. Zhan, L. Ma and G. Liang, Angew. Chem., Int. Ed., 2011, 123, 6288–6290 CrossRef; (d) M. Xiao, W. Wu, L. Wei, X. Jin, X. Yao and Z. Xie, Tetrahedron, 2015, 71, 3705–3714 CrossRef CAS.
  4. (a) T. S. Kam, G. Subramaniam, K. H. Lim and Y. M. Choo, Tetrahedron Lett., 2004, 45, 5995–5998 CrossRef CAS; (b) J. Magolan, C. A. Carson and M. A. Kerr, Org. Lett., 2008, 10, 1437–1440 CrossRef CAS PubMed; (c) J. Xiao, G. H. Zhou and C. B. Ji, ChemistrySelect, 2022, 7, e202201373 CrossRef CAS.
  5. (a) S. B. Fu, X. Feng, Q. F. Meng, Q. Cai and D. A. Sun, Nat. Prod. Res., 2018, 33, 1–7 Search PubMed; (b) G. A. Strobel, B. Knighton, K. Kluck, Y. Ren, T. Livinghouse, M. Griffin, D. Spakowicz and J. Sears, Microbiology, 2008, 154, 3319–3328 CrossRef CAS PubMed; (c) Z. Gan, J. Yang, N. Tao, Z. Yu and K. Q. Zhang, J. Microbiol., 2007, 422–430 CAS.
  6. (a) T. Kametani, N. Kanaya and M. Ihara, J. Am. Chem. Soc., 1980, 102, 3974–3975 CrossRef CAS; (b) T. Kametani, N. Kanaya and M. Ihara, J. Am. Chem. Soc., 1980, 102, 3974–3975 CrossRef CAS; (c) C. S. V. Ley and J. R. Frost, Synfacts, 2012, 8, 0241 CrossRef; (d) L. Zhao, J. P. May, J. Huang and D. M. Perrin, Org. Lett., 2012, 14, 90–93 CrossRef CAS PubMed.
  7. (a) G. S. Lee, G. Namkoong, J. Park and D. Y.-K. Chen, Chem.–Eur. J., 2017, 23, 16189–16193 CrossRef CAS PubMed; (b) U. Beifuss, Angew Chem. Int. Ed. Engl., 1994, 33, 1144–1149 CrossRef; (c) Y. Kaburagi, H. Tokuyama and T. Fukuyama, J. Am. Chem. Soc., 2004, 12, 10246–10247 CrossRef PubMed.
  8. (a) X. Huang, M. Ou, L. Hong, W. Qin and Y. Ma, ACS Catal., 2024, 14, 6432–6439 CrossRef CAS; (b) C. Liu, W. Zhang, L. X. Dai and S. L. You, Org. Lett., 2012, 14, 5168 CrossRef CAS; (c) Q. H. Liu, Y. Ma and H. Y. Zhang, Org. Chem. Front., 2024, 11, 1357–1365 RSC; (d) R. R. Liu, Y. G. Wang, Y. L. Li, B. B. Huang, R. X. Liang and P. D. Y.-X. Jia, Angew. Chem., Int. Ed., 2017, 56, 7475–7478 CrossRef CAS PubMed; (e) D. A. Petrone, A. Yen, N. Zeidan and M. Lautens, Org. Lett., 2015, 17, 4838–4841 CrossRef CAS PubMed; (f) D. Trauner and M. D. Zott, Synfacts, 2025, 21, 529 CrossRef; (g) W. J. Zhou, Z. H. Wang, L. L. Liao, Y. X. Jiang and D. G. Yu, Nat. Commun., 2020, 11, 3263 CrossRef CAS PubMed.
  9. (a) S.-B. Duan, X.-J. Gao, H.-Y. Zhang, C.-C. Lu, J. Zhao, Y.-P. Han, Y. Zhang and Y.-M. Liang, Arabian J. Chem., 2021, 14, 103155 CrossRef CAS; (b) Y. Li, H.-Y. Zhang, Y. Zhang, Y.-P. Han, J. Zhao and Y.-M. Liang, J. Org. Chem., 2021, 86, 14640–14651 CrossRef CAS PubMed; (c) D. A. Petrone, M. Kondo, N. Zeidan and M. Lautens, Chem.–Eur. J., 2016, 22, 5684–5691 CrossRef CAS PubMed.
  10. (a) S. Chen, L. Van Meervelt, E. V. Van der Eycken and U. K. Sharma, Org. Lett., 2022, 24, 1213–1218 CrossRef CAS PubMed; (b) Y. Y. Hu, X. Q. Xu, W. C. Deng, R. X. Liang and Y. X. Jia, Org. Lett., 2023, 25, 6122–6127 CrossRef CAS PubMed; (c) G. Wang, M. Wei, T. Liu, W. Jin, Y. Zhang, B. Wang, Y. Xia and C. Liu, Adv. Synth. Catal., 2022, 364, 909–913 CrossRef CAS.
  11. (a) S. Chen, X.-X. Wu, J. Wang, X.-H. Hao, Y. Xia, Y. Shen, H. Jing and Y.-M. Liang, Org. Lett., 2016, 18, 4016–4019 CrossRef CAS PubMed; (b) A. V. Coelho, A. L. F. de Souza, P. G. de Lima, J. L. Wardell and O. Antunes, Tetrahedron Lett., 2007, 48, 7671–7674 CrossRef CAS; (c) S.-B. Duan, H.-Y. Zhang, Y. Ma, J. Zhao, Y.-P. Han, Y. Zhang and Y.-M. Liang, J. Org. Chem., 2022, 87, 10917–10927 CrossRef CAS PubMed; (d) R.-R. Liu, T.-F. Xu, Y.-G. Wang, B. Xiang, J.-R. Gao and Y.-X. Jia, Chem. Commun., 2016, 52, 13664–13667 RSC; (e) I. A. Sanhueza, F. J. Klauck, E. Senol, S. T. Keaveney, T. Sperger and F. Schoenebeck, Angew. Chem., Int. Ed., 2021, 60, 7007–7012 CrossRef CAS PubMed; (f) H. Wang and X.-F. Wu, Org. Lett., 2019, 21, 5264–5268 CrossRef CAS PubMed; (g) F. Zhu, Z. Chen and M. A. Walczak, J. Org. Chem., 2020, 85, 11942–11951 CrossRef CAS PubMed.

Footnote

These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.